United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2019_register
executive
2019-03-28
article
Advisory Committee; Cellular, Tissue and Gene Therapies Advisory Committee, Renewal
Notices
D09002ee1c17255ce
D09002ee1c172564b
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA) is announcing the renewal of the Cellular, Tissue and Gene Therapies Advisory Committee (Committee) by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until October 28, 2020.
84 FR 11802
https://www.govinfo.gov/app/details/FR-2019-03-28/2019-05985
2019-05985
fr28mr19-61
4164-01-P
Docket No. FDA-2019-N-0428
https://www.govinfo.gov/app/details/FR-2019-03-28/2019-05985
https://www.govinfo.gov/content/pkg/FR-2019-03-28/html/2019-05985.htm
https://www.govinfo.gov/content/pkg/FR-2019-03-28/pdf/2019-05985.pdf
1 p.
11802
11802
84 FR 11802
Advisory Committee; Cellular, Tissue and Gene Therapies Advisory Committee, Renewal; Federal Register Vol. 84, Issue
NOTICE
2019-05985
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Docket No. FDA-2019-N-0428
4164-01-P
2019-05985
Notice; renewal of advisory committee.
The Food and Drug Administration (FDA) is announcing the renewal of the Cellular, Tissue and Gene Therapies Advisory Committee (Committee) by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until October 28, 2020.
Authority for the Cellular, Tissue and Gene Therapies Advisory Committee will expire on October 28, 2018, unless the Commissioner formally determines that renewal is in the public interest.
Prabhakara Atreya, Division of Scientific Advisors and Consultants, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 6306, Silver Spring, MD 20993; 240-402-8006, email: Prabhakara.atreya@fda.hhs.gov.
Charter Renewals:
Cellular, Tissue and Gene Therapies Advisory Committee
,
Prabhakara.atreya@fda.hhs.gov
https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/default.htm
https://www.fda.gov/AdvisoryCommittees/default.htm
Federal Register
Vol. 84, no. 60
Office of the Federal Register, National Archives and Records Administration
2019-03-28
continuing
daily
deposited
born digital
251 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2019-03-28
P0b002ee1a020e9c3
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr28mr19
https://www.govinfo.gov/app/details/FR-2019-03-28
https://www.govinfo.gov/content/pkg/FR-2019-03-28/pdf/FR-2019-03-28.pdf
https://www.govinfo.gov/content/pkg/FR-2019-03-28/xml/FR-2019-03-28.xml
fdlp
11637
11877
DGPO
2019-03-28
2023-10-10
FR-2019-03-28
machine generated
eng
FR
FR-2019-03-28
84
60